NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award (Parent [R44] Clinical Trial Optional)

The National Institutes of Health (NIH) is soliciting applications for the Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award. This award provides additional support to mitigate the funding gap for projects that require extraordinary time and effort, including those requiring regulatory approval or developing complex instrumentation, clinical research tools, or behavioral interventions. The main objective of a SBIR/STTR Phase II award is to continue R&D efforts to advance a technology toward commercialization. Key aspects of this opportunity include: * Eligibility: Only United States small business concerns (SBCs) that have previously received an NIH SBIR or STTR Phase II award are eligible to submit applications. * Award: The award provides funding for later-stage research and development (R&D) to advance a technology toward commercialization. * Project scope: The project scope includes continuing R&D efforts to advance a technology toward commercialization, and may involve regulatory approval, complex instrumentation, clinical research tools, or behavioral interventions. * Application submission: Applications are not being solicited at this time, but notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects.